Corneal collagen cross-linking (CXL) treatment

· Glaukos Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Corneal collagen cross-linking (CXL) treatment, covering 2016-07-07 to 2016-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Corneal Collagen Cross-linking for Progressive Keratoconus [Phase 3]